⌘K
Loading ticker…
As of 2026-08-24, Mineralys Therapeutics, Inc. Common Stock (MLYS) has a 3-month relative strength percentile of 24 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 48. The current market Stance is 47.8 (Neutral). Sector: Healthcare, ranked 3 of 11. Average daily range 4.3%, relative volume 0.77×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
MLYS is in a stage 4 downtrend, week 1. Extended from base. VCP detected: inconclusive. Distance from 50d / 200d: -5.3% / -16.7%.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
Diluted EPS, last 8 quarters. Loss makers are judged by progress toward breakeven.
MLYS is held by 24 ETFs as of May 2026. Top owner: SCHA at 0.04% weight, $8M notional. Top 3 carry $20M.
Held by 52 ETFs · $211M across latest filings · largest weight 1.59% (SBIO).
Top 10 by value, from SEC N-PORT-P filings dated May 2026.
| ETF | Weight | Value | Δ |
|---|---|---|---|
| SCHASchwab U.S. Small-Cap ETF | 0.04% | $8M | — |
| VTWO | 0.04% | $8M | — |
| VHTVanguard Health Care ETF | 0.02% | $4M | — |
| SBIO | 1.59% | $3M | +0.09 pp |
| VTWG | 0.08% | $1M | — |
Weak relative strength and quiet attention. Little to read here either way.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
Daily range, ATR, beta, and the math for a 1-ADR stop.
YoY sales growth, last 8 quarters. Sales must back the earnings story.
Operating margin unavailable
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
| 0.05% |
| $1M |
| +0.02 pp |
| SCHBSchwab U.S. Broad Market ETF | 0.00% | $1M | — |
| VFMO | 0.05% | $915K | −0.09 pp |
| ONEQ | 0.01% | $699K | — |
| IBBQ | 0.20% | $134K | +0.03 pp |
Showing 10 of 24 ETF owners.
As filed in N-PORT — quarterly holdings with up to ~60-day publication lag. Not live positioning.
Related searches
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | MLYS Jan avg: -1.45% median: -14.88% win: 33% σ: 24.53% n: 3 2023-02-13 → 2026-07-31 | MLYS Feb avg: 5.21% median: -4.43% win: 25% σ: 24.07% n: 4 2023-02-13 → 2026-07-31 | MLYS Mar avg: 9.59% median: -9.67% win: 25% σ: 42.92% n: 4 2023-02-13 → 2026-07-31 | MLYS Apr avg: -7.84% median: -7.81% win: 0% σ: 5.56% n: 4 2023-02-13 → 2026-07-31 | MLYS May avg: 10.05% median: 8.87% win: 100% σ: 5.89% n: 4 2023-02-13 → 2026-07-31 | MLYS Jun avg: -4.66% median: -10.77% win: 25% σ: 14.84% n: 4 2023-02-13 → 2026-07-31 | MLYS Jul avg: -3.01% median: -0.41% win: 50% σ: 10.68% n: 4 2023-02-13 → 2026-07-31 | MLYS Aug avg: 0.14% median: 0.16% win: 67% σ: 9.26% n: 3 2023-02-13 → 2026-07-31 (current) | MLYS Sep avg: 38.87% median: -2.42% win: 33% σ: 92.63% n: 3 2023-02-13 → 2026-07-31 | MLYS Oct avg: -0.16% median: 7.75% win: 67% σ: 16.13% n: 3 2023-02-13 → 2026-07-31 | MLYS Nov avg: -4.29% median: -4.56% win: 33% σ: 9.69% n: 3 2023-02-13 → 2026-07-31 | MLYS Dec avg: 3.23% median: -3.60% win: 33% σ: 23.25% n: 3 2023-02-13 → 2026-07-31 |